{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T11:28:25Z","timestamp":1782905305741,"version":"3.54.5"},"update-to":[{"DOI":"10.1002\/14651858.cd009764.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,10,30]],"date-time":"2018-10-30T00:00:00Z","timestamp":1540857600000}}],"reference-count":119,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009764.pub3","type":"journal-article","created":{"date-parts":[[2018,10,30]],"date-time":"2018-10-30T15:57:39Z","timestamp":1540915059000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD)"],"prefix":"10.1002","volume":"2018","author":[{"given":"Samantha C","family":"Herath","sequence":"first","affiliation":[{"name":"Westmead Public Hospital; Department of Respiratory and Sleep Medicine; Sydney New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Normansell","sequence":"additional","affiliation":[{"name":"St George's, University of London; Cochrane Airways, Population Health Research Institute; London UK SW17 0RE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Maisey","sequence":"additional","affiliation":[{"name":"St George's University of London; Population Health Research Institute; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillippa","family":"Poole","sequence":"additional","affiliation":[{"name":"University of Auckland; Department of Medicine; Private Bag 92019 Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,10,30]]},"reference":[{"key":"10.1002\/14651858.CD009764.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa1104623","article-title":"Azithromycin for prevention of exacerbations of COPD","volume":"365","author":"Albert","year":"2011","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"10.1002\/14651858.CD009764.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1164\/rccm.201402-0207OC","article-title":"Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapy","volume":"189","author":"Han","year":"2014","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0003|cit3","first-page":"A4383","article-title":"Chronic azithromycin therapy decreases the risk of re-hospitalization in patients with COPD","volume":"187","author":"Martinez","year":"2013","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"12","key":"10.1002\/14651858.CD009764.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"e004140","DOI":"10.1136\/bmjopen-2013-004140","article-title":"Sputum PGP is reduced by azithromycin treatment in patients with COPD and correlates with exacerbations","volume":"3","author":"O'Reilly","year":"2013","journal-title":"BMJ Open"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"295-8","DOI":"10.1183\/09031936.00140613","article-title":"Tumour necrosis factor receptor-75 and risk of COPD exacerbation in the azithromycin trial","volume":"43","author":"Woodruff","year":"2014","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2165\/00151829-200403010-00007","article-title":"The effect of oral Clarithromycin on bronchial airway inflammation in moderate-to-severe stable COPD: a randomised controlled trial","volume":"3","author":"Banerjee","year":"2004","journal-title":"Treatments in Respiratory Medicine"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.rmed.2004.06.009","article-title":"The effect of oral clarithromycin on health status and sputum bacteriology in stable COPD","volume":"99","author":"Banerjee","year":"2005","journal-title":"Respiratory Medicine"},{"issue":"1","key":"10.1002\/14651858.CD009764.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1465-9921-14-125","article-title":"Azithromycin and cough-specific health status in patients with chronic obstructive pulmonary disease and chronic cough: a randomised controlled trial","volume":"14","author":"Berkhof","year":"2013","journal-title":"Respiratory Research"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0009|cit9","first-page":"A2449","article-title":"Randomized controlled trial of prophylactic azithromycin on cough-specific health status in patients with chronic obstructive pulmonary disease","volume":"187","author":"Berkhof","year":"2013","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0010|cit10","first-page":"OA4746","article-title":"Haemophilus dominance of the stable COPD microbiome is associated with greater bacterial load and inflammation and is modulated by prophylactic antibiotic therapy","volume":"46","author":"Brill","year":"2015","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0011|cit11","first-page":"P4731","article-title":"Bacterial resistance induction with prophylactic antibiotics in COPD","volume":"44","author":"Brill","year":"2014","journal-title":"European Respiratory Journal"},{"issue":"10","key":"10.1002\/14651858.CD009764.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1136\/thoraxjnl-2015-207194","article-title":"Effects of different antibiotic classes on airway bacteria in stable COPD using culture and molecular techniques: a randomised controlled trial","volume":"70","author":"Brill","year":"2015","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0013|cit13","first-page":"A2874","article-title":"Effect of antibiotics on airway bacteria in patients with chronic obstructive pulmonary disease","volume":"198","author":"Brill","year":"2014","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1159\/000321374","article-title":"Effect of 6 months of erythromycin treatment on inflammatory cells in induced sputum and exacerbations in chronic obstructive pulmonary disease","volume":"80","author":"He","year":"2010","journal-title":"Respiration"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0015|cit15","unstructured":"Mygind LH Pedersen C Vestbo J Christensen JJ Frimodt-Moller N Kristiansen IS A randomised, placebo-controlled 3 years study of prophylactic azithromycin in 575 patients with chronic obstructive pulmonary disease European Respiratory Society 20th Annual Congress; 2010 Sep 18-22; Barcelona 2010"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0016|cit16","unstructured":"NCT00524095 Bronchiectasis in chronic obstructive pulmonary disease (COPD) patients: role of prophylaxis clinicaltrials.gov\/ct2\/show\/NCT00524095"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0017|cit17","unstructured":"Batista CM A bench to bedside investigation into defective innate immunity in chronic obstructive pulmonary disease National Heart & Lung Institute, Imperial College London, UK; 2018"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0018|cit18","unstructured":"NCT02628769 A study to evaluate the anti-inflammatory effects of solithromycin in chronic obstructive pulmonary disease clinicaltrials.gov\/ct2\/show\/NCT02628769"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1164\/rccm.200801-145OC","article-title":"Long-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbations","volume":"178","author":"Seemungal","year":"2008","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1465-9921-11-10","article-title":"Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized control trial","volume":"11","author":"Sethi","year":"2010","journal-title":"Respiratory Research"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12952-015-0034-8","article-title":"A double-blind, randomised, placebo-controlled study of roxithromycin and doxycycline combination, roxithromycin alone, or matching placebo for 12 weeks in adults with frequent exacerbations of chronic obstructive pulmonary disease","volume":"14","author":"Shafuddin","year":"2015","journal-title":"Journal of Negative Results in Biomedicine"},{"issue":"8","key":"10.1002\/14651858.CD009764.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"e105609","DOI":"10.1371\/journal.pone.0105609","article-title":"The effect of azithromycin in adults with stable neutrophilic COPD: a double blind randomised, placebo controlled trial","volume":"9","author":"Simpson","year":"2014","journal-title":"PLOS One"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1378\/chest.120.3.730","article-title":"Erythromycin and common cold in COPD","volume":"120","author":"Suzuki","year":"2001","journal-title":"Chest"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"387A","DOI":"10.1016\/j.chest.2016.02.402","article-title":"Effects of low-dose and long-term treatment with erythromycin on IL-17 and IL-23 in peripheral blood and induced sputum in patients with stable chronic obstructive pulmonary disease","volume":"149","author":"Tan","year":"2016","journal-title":"Chest"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"4173962","DOI":"10.1155\/2016\/4173962","article-title":"Effects of low-dose and long-term treatment with erythromycin on interleukin-17 and interleukin-23 in peripheral blood and induced sputum in patients with stable chronic obstructive pulmonary disease","author":"Tan","year":"2016","journal-title":"Mediators of Inflammation"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0026|cit26","first-page":"PA3713","article-title":"Which predictors in COPD patients with the frequent exacerbator phenotype predict the treatment response to maintenance therapy with azithromycin?","volume":"48","author":"Djamin","year":"2016","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0027|cit27","first-page":"A5967","article-title":"Patients with COPD Gold C & D: the effect of long-term treatment with azithromycin on exacerbation risk assessed by the Gold Framework","volume":"189","author":"Uzun","year":"2014","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"5","key":"10.1002\/14651858.CD009764.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S2213-2600(14)70019-0","article-title":"Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): a randomised, double-blind,placebo-controlled trial","volume":"2","author":"Uzun","year":"2014","journal-title":"Lancet Respiratory Medicine"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0029|cit29","first-page":"A2884","article-title":"Effect of azithromycin maintenance treatment in patients with frequent exacerbations of COPD (columbus): a randomized, double-blind, placebo-controlled trial","volume":"189","author":"Uzun","year":"2014","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"2","key":"10.1002\/14651858.CD009764.pub3-BIB0030|cit30","first-page":"260","article-title":"Effect of azithromycin in combination with simvastatin in the treatment of chronic obstructive pulmonary disease complicated by pulmonary arterial hypertension","volume":"33","author":"Wang","year":"2017","journal-title":"Pakistan Journal of Medicine Science"},{"issue":"1","key":"10.1002\/14651858.CD009764.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.2147\/COPD.S117652","article-title":"Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype - a post-hoc analysis of a randomized, double-blind, placebo-controlled clinical trial","volume":"11","author":"Beeh","year":"2016","journal-title":"International Journal of COPD"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0032|cit32","first-page":"642","article-title":"Trial of preventive treatment of patients with chronic bronchitis","volume":"37","author":"Beier","year":"1971","journal-title":"Wiener Medizinische Wochenschrift"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.pupt.2009.12.002","article-title":"Long term azithromycin use in patients with chronic obstructive pulmonary disease and tracheostomy","volume":"23","author":"Blasi","year":"2010","journal-title":"Pulmonary Pharmacology and Theraputics"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0034|cit34","first-page":"483","article-title":"Prophylactic administration of Bactrim in chronic bronchitis","volume":"5-6","author":"Bruninx","year":"1973","journal-title":"Acta Tuberculosea et Pneumologica Belgica"},{"issue":"7049","key":"10.1002\/14651858.CD009764.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0140-6736(58)91334-5","article-title":"Long term prophylactic administration of tetracycline to chronic bronchitis","volume":"2","author":"Buchanan","year":"1958","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD009764.pub3-BIB0036|cit36","first-page":"351","article-title":"Assessment of chemoprophylaxis with intermittent tetracycline in chronic-bronchitis - a functional follow-up for 3 years","volume":"8","author":"Bussi","year":"1980","journal-title":"Revue Francaise des Maladies Respiratoires"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0002-9343(61)90125-5","article-title":"Bacterial Infection and some effects of chemoprophylaxis in chronic pulmonary emphysema","volume":"31","author":"Davies","year":"1961","journal-title":"American Journal of Medicine"},{"issue":"6988","key":"10.1002\/14651858.CD009764.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0140-6736(57)91597-0","article-title":"Effect of antibiotics on purulent sputum","volume":"273","author":"Douglas","year":"1957","journal-title":"Lancet"},{"issue":"5103","key":"10.1002\/14651858.CD009764.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1136\/bmj.2.5103.1010","article-title":"Adult chronic bronchitis - continuous antibiotic therapy","volume":"2","author":"Edwards","year":"1958","journal-title":"British Medical Journal"},{"issue":"5056","key":"10.1002\/14651858.CD009764.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1136\/bmj.2.5056.1272","article-title":"Prophylactic use of oxytetracycline for exacerbations of chronic bronchitis","volume":"2","author":"Elmes","year":"1957","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0007-0971(68)80040-3","article-title":"A five year study of bacteriology and prophylactic chemotherapy in patients with chronic bronchitis","volume":"62","author":"Calder","year":"1968","journal-title":"British Journal of Diseases of the Chest"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1136\/bmj.1.5499.1317","article-title":"Value of chemoprophylaxis and chemotherapy in early chronic bronchitis. A report to the Medical Research Council by their working party on trials of chemotherapy in early chronic bronchitis","volume":"1","author":"Fletcher","year":"1966","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1136\/bmj.1.5385.728","article-title":"Influence of daily penicillin, tetracycline, erythromycin and sulphamethoxypyridazine on exacerbation of bronchitis","volume":"1","author":"Frances","year":"1964","journal-title":"British Medical Journal"},{"issue":"1","key":"10.1002\/14651858.CD009764.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/bmj.1.5169.297","article-title":"Chemotherapy in chronic bronchitis. Influence of daily penicillin and tetracycline on exacerbations and their cost","volume":"30","author":"Francis","year":"1960","journal-title":"British Medical Journal"},{"issue":"3","key":"10.1002\/14651858.CD009764.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1378\/chest.52.3.376","article-title":"Continous suppressive antimicrobial treatment in chronic infected bronchitis during winter months","volume":"52","author":"Goslings","year":"1967","journal-title":"Disease of the Chest"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1378\/chest.113.1.131","article-title":"A 1-year community based health economic study of ciprofloxacin treatment in acute exacerbations of chronic bronchitis: the Canadian Ciprofloxacin Health Economics Study Group","volume":"113","author":"Grossman","year":"1998","journal-title":"Chest"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2165\/00019053-199916050-00007","article-title":"Economic evaluation of ciprofloxacin compared with usual anti-bacterial care for the treatment of acute exacerbations of chronic bronchitis in patients followed for 1 year","volume":"16","author":"Torrance","year":"1999","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"10.1002\/14651858.CD009764.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1128\/AAC.2.1.45","article-title":"Ampicillin and tetracyclin in the treatment and prophylaxis of chronic bronchitis","volume":"2","author":"Hahn","year":"1972","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"9","key":"10.1002\/14651858.CD009764.pub3-BIB0049|cit49","first-page":"514","article-title":"Effect of inhalation of tobramycin for 12 months on reduction of hospitalisation rate in severe COPD","volume":"67","author":"Haidl","year":"2013","journal-title":"Pneumologie"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0050|cit50","first-page":"716","article-title":"Chemoprophylaxis in chronic obstructive pulmonary emphysema","volume":"80","author":"Hallet","year":"1959","journal-title":"Chemoprophylaxis in Emphysema"},{"issue":"6839","key":"10.1002\/14651858.CD009764.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0140-6736(56)91240-5","article-title":"Long-term oxytetracycline (Terramycin) therapy in advanced chronic respiratory infections","volume":"267","author":"Helm","year":"1956","journal-title":"Lancet"},{"issue":"5258","key":"10.1002\/14651858.CD009764.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1136\/bmj.2.5258.985","article-title":"A trial of phenethicillin in chronic bronchitis","volume":"2","author":"Johnston","year":"1961","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/bmj.4.5678.265","article-title":"Five year winter prophylaxis for chronic bronchitis","volume":"4","author":"Johnston","year":"1969","journal-title":"British Medical Journal"},{"issue":"4884","key":"10.1002\/14651858.CD009764.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/bmj.2.4884.385","article-title":"Sulphonmide prophylaxis in chronic bronchitis","volume":"2","author":"Kilpatrick","year":"1954","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0055|cit55","first-page":"883","article-title":"Double blind long term study on a combination of tetracycline, theophylline, doxylamine succinate , etafedrine, phenylephedrine and guaifenesine in chronic bronchitis","volume":"27","author":"Legler","year":"1977","journal-title":"Arzneimittel-Forschung"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0954-6820.1987.tb01280.x","article-title":"Trimethoprim prophylaxis of acute exacerbations in chronic obstructive pulmonary disease","volume":"221","author":"Liippo","year":"1987","journal-title":"Acta Medica Scandinavica"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/1753465810368552","article-title":"Prophylactic antibiotic therapy in chronic obstructive pulmonary disease","volume":"4","author":"Maraffi","year":"2010","journal-title":"Theraputic Advances in Respiratory Disease"},{"issue":"1","key":"10.1002\/14651858.CD009764.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"27","DOI":"10.5414\/ATX01973","article-title":"Antibiotic use in patients with COPD receiving EPs 7630 as an add-on treatment","volume":"41","author":"Matthys","year":"2016","journal-title":"Atemwegs-und Lungenkrankheiten"},{"issue":"6947","key":"10.1002\/14651858.CD009764.pub3-BIB0059|cit59","first-page":"814","article-title":"Long term chemotherapy in chronic bronchitis","volume":"271","author":"May","year":"1956","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1183\/09031936.00195608","article-title":"Efficacy of moxifloxacin in the treatment of bronchial colonisation in COPD","volume":"34","author":"Miravitlles","year":"2009","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0041-3879(59)80150-1","article-title":"Prophylactic chemotherapy in chronic bronchitis","volume":"40","author":"Moyes","year":"1959","journal-title":"Tubercle"},{"issue":"5162","key":"10.1002\/14651858.CD009764.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1136\/bmj.2.5162.1277","article-title":"An evaluation of continuous antibiotic therapy in chronic bronchitis","volume":"2","author":"Murdoch","year":"1959","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0063|cit63","first-page":"244","article-title":"A trial of ampicillin in chronic bronchitis","volume":"7","author":"Murray","year":"1964","journal-title":"Journal of the College of General Practitioners"},{"issue":"4","key":"10.1002\/14651858.CD009764.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s11845-015-1372-8","article-title":"Assessing potential risks of treatment with long-term azithromycin in COPD patients: long-term oxygen users beware?","volume":"185","author":"Nicholson","year":"2016","journal-title":"Irish Journal of Medical Science"},{"issue":"11","key":"10.1002\/14651858.CD009764.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1001\/jama.1962.03050110001001","article-title":"Long term tetracycline treatment of chronic bronchitis","volume":"179","author":"Norman","year":"1962","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1136\/bmj.3.5559.202","article-title":"Controlled trials of a sulphonamide given weekly to prevent exacerbations of chronic bronchitis","volume":"3","author":"Pines","year":"1967","journal-title":"British Medical Journal"},{"issue":"7153","key":"10.1002\/14651858.CD009764.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0140-6736(60)91792-X","article-title":"A trial of continuous winter chemotherapy in chronic bronchitis","volume":"2","author":"Pridie","year":"1960","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.rmed.2015.10.009","article-title":"Effects of doxycycline on local and systemic inflammation in stable COPD patients, a randomized clinical trial","volume":"110","author":"Prins","year":"2016","journal-title":"Respiratory Medicine"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0069|cit69","first-page":"955","article-title":"Chemoprophylaxis with erythromycin stearate or amoxacillin in patients with chronic bronchitis - effects on cellular and humoral immune functions","volume":"66","author":"Ras","year":"1984","journal-title":"South African Medical Journal"},{"issue":"1","key":"10.1002\/14651858.CD009764.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/thoraxjnl-2016-208599","article-title":"Randomised, double-blind, placebo-controlled trial with azithromycin selects for anti-inflammatory microbial metabolites in the emphysematous lung","volume":"72","author":"Segal","year":"2017","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0071|cit71","first-page":"A2475","article-title":"Effects of azithromycin on lung microbiome, metabolome and immune phenotype of early emphysema subjects: a randomized controlled pilot study (Abstract)","volume":"189","author":"Segal","year":"2017","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0072|cit72","first-page":"179","article-title":"Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial","volume":"9","author":"Siva","year":"2014","journal-title":"International Journal of Chronic Obstructive Pulmonary Disease"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0073|cit73","first-page":"A1507","article-title":"Lung deposition of ciprofloxacin dry powder for inhalation in healthy subjects and patients suffering from chronic obstructive pulmonary disease or non-cystic fibrosis bronchiectasis","volume":"187","author":"Stass","year":"2013","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0007-0971(70)80050-X","article-title":"Prevention of exacerbations of bronchitis: trial of a long acting sulphonamide","volume":"64","author":"Vandenbergh","year":"1970","journal-title":"British Journal of Diseases of the Chest"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0075|cit75","first-page":"A1021","article-title":"Long-term effects of antibiotics in COPD exacerbations: a randomized clinical trial","volume":"193","author":"Velzen","year":"2016","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0076|cit76","first-page":"OA1506","article-title":"Time-to-treatment failure in the Belgian randomized controlled trial with azithromycin for acute COPD exacerbations requiring hospitalization","volume":"48","author":"Vermeersch","year":"2016","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2147\/COPD.S95501","article-title":"The Belgian trial with azithromycin for acute COPD exacerbations requiring hospitalization: an investigator-initiated study protocol for a multicenter, randomized, double-blind, placebo-controlled trial","volume":"11","author":"Vermeersch","year":"2016","journal-title":"International Journal of Chronic Obstructive Pulmonary Disease"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"S384","DOI":"10.1007\/BF01715833","article-title":"Once daily versus every two week multidose ofloxacin in patients with acute exacerbations of chronic respiratory disease","volume":"19","author":"Watanabe","year":"1991","journal-title":"Infection"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0079|cit79","first-page":"1194","article-title":"A well-controlled comparative clinical study of the combination regimen of ciprofloxacin plus erythromycin for the treatment of repeated acute exacerbations of chronic respiratory tract infections","volume":"42","author":"Watanabe","year":"1994","journal-title":"Chemotherapy"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1620\/tjem.176.25","article-title":"Daily single-dose regimen and alternate two-week triple dose\/day regimen of oral ofloxacin for the prophylaxis and control of exacerbations of chronic respiratory tract infections","volume":"176","author":"Watanabe","year":"1995","journal-title":"Tohoku Journal of Experimental Medicine"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/thx.26.3.319","article-title":"A double blind cross-over trail of trimethoprim and sulphamethoxazole in chronic bronchitis","volume":"26","author":"Webster","year":"1971","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0082|cit82","first-page":"240","article-title":"Antibiotic prophylaxis in primary antibody deficiency patients: study design PT","volume":"37","author":"Milito","year":"2017","journal-title":"Journal of Clinical Immunology"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0083|cit83","unstructured":"ChiCTR-IOR-16008820 Effect of low-dose erythromycin on the treatment of COPD apps.who.int\/trialsearch\/Trial2.aspx?TrialID=ChiCTR-IOR-16008820"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0084|cit84","unstructured":"NCT02205242 BACE trial substudy 1 - PROactive substudy (PROactive) clinicaltrials.gov\/show\/NCT02205242"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0085|cit85","unstructured":"NCT02205255 BACE trial substudy 2 - FarmEc substudy (FarmEc) clinicaltrials.gov\/ct2\/show\/NCT02205255"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0086|cit86","unstructured":"NCT02305940 Effects of long term antibiotic therapy on exacerbation rate in stable COPD patients clinicaltrials.gov\/show\/NCT02305940"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0087|cit87","first-page":"555","article-title":"Lung microbiology and exacerbations in COPD","volume":"7","author":"Beasley","year":"2012","journal-title":"International Journal of Chronic Obstructive Pulmonary Disease"},{"issue":"4","key":"10.1002\/14651858.CD009764.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/thorax.58.4.339","article-title":"Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ)","volume":"58","author":"Birring","year":"2003","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0089|cit89","volume-title":"British National Formulary","author":"Joint Formulary Committee","year":"2018"},{"issue":"9","key":"10.1002\/14651858.CD009764.pub3-BIB0090|cit90","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002309.pub3","article-title":"Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease","author":"Chong","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0091|cit91","unstructured":"Global Initiative for Chronic Obstructive Lung Disease Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2018 report) goldcopd.org\/wp-content\/uploads\/2017\/11\/GOLD-2018-v6.0-FINAL-revised-20-Nov_WMS.pdf"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1136\/thx.42.10.773","article-title":"A measure of quality of life for clinical trials in chronic lung disease","volume":"42","author":"Guyatt","year":"1987","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2147\/COPD.S77092","article-title":"Length of stay of COPD hospital admissions between 2006 and 2010: a retrospective longitudinal study","volume":"10","author":"Harries","year":"2015","journal-title":"International Journal of Chronic Obstructive Pulmonary Disease"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0094|cit94","unstructured":"Higgins JPT Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1164\/rccm.200505-704OC","article-title":"Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease","volume":"173","author":"Hurst","year":"2006","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0096|cit96","unstructured":"Jones P St George's Respiratory Questionnaire Manual Version 2.3 www.healthstatus.sgul.ac.uk\/SGRQ_download\/SGRQ%20Manual%20June%202009.pdf"},{"issue":"3","key":"10.1002\/14651858.CD009764.pub3-BIB0097|cit97","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010115.pub2","article-title":"Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease","author":"Kew","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD009764.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s11606-007-0118-3","article-title":"Impact of pneumococcal vaccination on pneumonia rates in patients with COPD and asthma","volume":"22","author":"Lee","year":"2007","journal-title":"Journal of General Internal Medicine"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2147\/COPD.S681","article-title":"Role of macrolide therapy in chronic obstructive pulmonary disease","volume":"3","author":"Martinez","year":"2008","journal-title":"International Journal of Chronic Obstructive Pulmonary Disease"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2147\/COPD.S132961","article-title":"Bronchiectasis in COPD patients: more than a comorbidity?","volume":"12","author":"Martinez-Garcia","year":"2017","journal-title":"International Journal of Chronic Obstructive Pulmonary Disease"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.rmed.2012.10.024","article-title":"Chronic bronchial infection in COPD. Is there an infective phenotype?","volume":"107","author":"Matkovic","year":"2013","journal-title":"Respiratory Medicine"},{"issue":"4","key":"10.1002\/14651858.CD009764.pub3-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1128\/AAC.02011-12","article-title":"Blood, tissue, and intracellular concentrations of azithromycin during and after end of therapy","volume":"57","author":"Matzneller","year":"2013","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"1","key":"10.1002\/14651858.CD009764.pub3-BIB0103|cit103","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan - a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Systematic Reviews"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1513\/pats.200512-125SF","article-title":"Pathophysiology of exacerbations of chronic obstructive pulmonary disease","volume":"3","author":"Papi","year":"2006","journal-title":"Proceedings of the American Thoracic Society"},{"issue":"8","key":"10.1002\/14651858.CD009764.pub3-BIB0105|cit105","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001287.pub4","article-title":"Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease","author":"Poole","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0106|cit106","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2008"},{"issue":"3","key":"10.1002\/14651858.CD009764.pub3-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/thx.2005.041822","article-title":"COPD exacerbations 2: aetiology","volume":"61","author":"Sapey","year":"2006","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1056\/NEJMra0800353","article-title":"Infection in the pathogenesis and course of chronic obstructive pulmonary disease","volume":"359","author":"Sethi","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD009764.pub3-BIB0109|cit109","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004105","article-title":"Prophylactic antibiotic therapy for chronic bronchitis","author":"Staykova","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"144","key":"10.1002\/14651858.CD009764.pub3-BIB0110|cit110","first-page":"149","article-title":"Impact of salmeterol\/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease","volume":"175","author":"Kardos","year":"2007","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0111|cit111","unstructured":"Thoracic Society of Australia and New Zealand (New Zealand Branch) Standards for adult respiratory and sleep services in New Zealand www.health.govt.nz\/system\/...\/standardsforadultrespiratoryandsleepservices.doc"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJMoa0805800","article-title":"4-year trial of tiotropium in chronic obstructive pulmonary disease","volume":"359","author":"Tashkin","year":"2008","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0113|cit113","unstructured":"Visual Rx www.nntonline.net\/visualrx\/ (accessed October 2013)"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1365-2710.2011.01285.x","article-title":"Effect of long-acting beta-agonists on the frequency of COPD exacerbations: a meta-analysis","volume":"37","author":"Wang","year":"2012","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD009764.pub3-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJMct1115170","article-title":"Antibiotic prevention of acute exacerbations of COPD","volume":"367","author":"Wenzel","year":"2012","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD009764.pub3-BIB0116|cit116","unstructured":"World Health Organization Chronic obstructive pulmonary disease www.who.int\/respiratory\/copd\/en\/"},{"issue":"2","key":"10.1002\/14651858.CD009764.pub3-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1378\/chest.129.2.317","article-title":"Effects of interactions between lower airway bacterial and rhinoviral infections in exacerbations of COPD","volume":"129","author":"Wilkinson","year":"2006","journal-title":"Chest"},{"issue":"6","key":"10.1002\/14651858.CD009764.pub3-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1469-0691.2011.03672.x","article-title":"Guidelines for the management of adult lower respiratory tract infections","volume":"17","author":"Woodhead","year":"2011","journal-title":"Clinical Microbiology and Infection"},{"issue":"11","key":"10.1002\/14651858.CD009764.pub3-BIB0119|cit119","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009764.pub2","article-title":"Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD)","author":"Herath","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD009764.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,22]],"date-time":"2021-08-22T12:05:17Z","timestamp":1629633917000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009764.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Airways Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,10,30]]},"references-count":119,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009764.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,30]]}}}